TB-500 5 mgPakkaus 10 ampullia5 varastossaSäästä 20 %
Nostettupeptideintermediate5 varastossa

TB-500 5 mg

Aktiinia sitova tutkimuspeptidi

Buy TB-500 in Australia for actin-binding research. Lab-verified, lyophilised, Australian-shipped.

Strength
Annos
5mg / ampulli
Muoto
Lyofilisoitu jauhe
Pakkaus
Pakkaus 10 ampullia

Vain tutkimuskäyttöön. Tämä yhdiste myydään tiukasti in vitro -tutkimukseen ja laboratoriotarkoituksiin, eikä se ole tarkoitettu ihmisravinnoksi tai terapeuttiseen käyttöön. Ostamalla vahvistat olevasi pätevä tutkija ja hyväksyt täyden vastuuvapauslausekkeemme.

160 € EUR
Säästä 20 %
Pakkaus 10 ampullia
Ennen 200 € EUR
Myydään 10 ampullin pakkauksena

Vain 5 pakkausta jäljellä

🧪Laboratoriovarmennettu
✓Kolmannen osapuolen testaama
⚡Nopea toimitus ympäri maailmaa
🔒Turvallinen korttimaksu
Yleiskatsaus

Tymosiini beeta-4 -fragmentti, jota on tutkittu solujen migraation, aktiinin säätelyn ja kudoksen uudelleenmuovauksen osalta tutkimussovelluksissa.

TB-500 is a synthetic peptide fragment of the naturally occurring protein thymosin β-4. The molecule contains the active actin-binding domain of full-length thymosin β-4 and has been extensively studied for its role in cell migration, wound-healing models, and tissue regeneration pathways. Quantum Labs supplies TB-500 as a lyophilised powder in sealed vials for Australian research applications.

TB-500 is most often studied alongside BPC-157 in tissue-repair research, where the two compounds target complementary mechanisms — BPC-157 acting predominantly through nitric oxide and VEGF pathways, TB-500 acting on actin sequestration and cytoskeletal remodelling. Our BPC-157 + TB-500 research stack supplies both compounds in pre-portioned vials.

Material ships from Australian stock, HPLC-verified to ≥99% purity with batch-level certificates of analysis available on request.

Mekanismi

Tutkittu G-aktiinin sitoutumisen ja solumigraatiomerkkien vaikutuksen osalta. Tutkimus viittaa mahdollisiin hyötyihin kudoskorjausreiteille.

Laboratorioraportti

HPLC-varmennettu ≥99 % puhtausspesifikaatiota vasten. Riippumattomasti testattu akkreditoiduissa kolmannen osapuolen laboratorioissa.

Mechanism in research literature

TB-500 contains the LKKTETQ actin-binding sequence from thymosin β-4. In research models, this peptide region has been shown to modulate actin polymerisation, promote endothelial cell migration, and influence the differentiation of mesenchymal stem cells toward repair phenotypes. The full mechanism is still under investigation in pre-clinical literature.

Tutkijoiden FAQ

TB-500 — usein kysytyt kysymykset

What is TB-500?

TB-500 is a synthetic fragment of the naturally occurring protein thymosin β-4, containing the active actin-binding domain. It is supplied for laboratory research into cell-migration and tissue-repair pathways.

Is TB-500 legal in Australia?

TB-500 is restricted for compounded human therapeutic supply in Australia. Research-grade TB-500 supplied without therapeutic representation remains available for laboratory use. Quantum Labs supplies TB-500 for research use only.

What is the typical TB-500 research dosage?

Published animal studies have used TB-500 doses in the 2-10 mg/kg range for systemic models. Human therapeutic dosing is not established. Researchers should reference primary literature for protocol-specific dosing.

Can TB-500 be used with BPC-157?

Combined BPC-157 + TB-500 protocols are common in tissue-repair research. The two compounds are believed to act on complementary pathways — BPC-157 on nitric oxide and VEGF, TB-500 on actin and cell migration. Quantum Labs supplies a BPC-157 + TB-500 research stack in pre-portioned vials.

What's the difference between TB-500 and thymosin β-4?

Full-length thymosin β-4 is a 43-amino-acid endogenous protein. TB-500 is the shorter active fragment containing the LKKTETQ actin-binding sequence. The shorter fragment is more practical for research-grade synthesis and is the form most studied in pre-clinical tissue-repair literature.

How is TB-500 stored?

Lyophilised TB-500 is stable at 2-8°C in unopened sealed vials. Once reconstituted, the working solution is typically stored at 2-8°C and used within 30 days. Avoid freeze-thaw cycles.

Lisälukemista

TB-500 liittyvät oppaat

Liittyvät yhdisteet

Tutkijat tutkivat myös